| Literature DB >> 26627310 |
Jamee M Berg1, Changhoon Lee2, Leslie Chen2, Laurie Galvan3, Carlos Cepeda3, Jane Y Chen3, Olga Peñagarikano2, Jason L Stein2, Alvin Li2, Asami Oguro-Ando2, Jeremy A Miller2, Ajay A Vashisht4, Mary E Starks2, Elyse P Kite2, Eric Tam2, Amos Gdalyahu5, Noor B Al-Sharif3, Zachary D Burkett6, Stephanie A White6, Scott C Fears3, Michael S Levine3, James A Wohlschlegel4, Daniel H Geschwind7.
Abstract
Autism spectrum disorder (ASD) is a heritable, common neurodevelopmental disorder with diverse genetic causes. Several studies have implicated protein synthesis as one among several of its potential convergent mechanisms. We originally identified Janus kinase and microtubule-interacting protein 1 (JAKMIP1) as differentially expressed in patients with distinct syndromic forms of ASD, fragile X syndrome, and 15q duplication syndrome. Here, we provide multiple lines of evidence that JAKMIP1 is a component of polyribosomes and an RNP translational regulatory complex that includes fragile X mental retardation protein, DEAD box helicase 5, and the poly(A) binding protein cytoplasmic 1. JAKMIP1 loss dysregulates neuronal translation during synaptic development, affecting glutamatergic NMDAR signaling, and results in social deficits, stereotyped activity, abnormal postnatal vocalizations, and other autistic-like behaviors in the mouse. These findings define an important and novel role for JAKMIP1 in neural development and further highlight pathways regulating mRNA translation during synaptogenesis in the genesis of neurodevelopmental disorders.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26627310 PMCID: PMC4829343 DOI: 10.1016/j.neuron.2015.10.031
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173